Clearline Capital LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.70B2026 Q3+ $466.3M options (notional, not included)
Positions118
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.46.6%

Clearline Capital LP reported 118 positions worth $1.70B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: SPY (19.8%). Biggest move: new buy SPY ($428.0M).

10 / 118 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SPYPutSPDR S&P 500$428.0M notional19.75%561,200———
▸ 2 CORZCore Scientific$118.6M5.47%7,422,853——-15.0%
▸ 3 AVGOBroadcom$76.7M3.54%218,489——-5.1%
▸ 4 AMZNAmazon$60.4M2.79%242,516——+3.5%
▸ 5 FTAIFTAI Aviation$59.3M2.74%354,974——+1.7%
▸ 6 WULFTerawulf$56.2M2.59%3,795,006——-19.7%
▸ 7 ROGRogers$53.6M2.47%350,202——-19.3%
▸ 8 HPEHewlett Packard$53.1M2.45%830,363——-27.1%
▸ 9 GDSGDS$52.5M2.42%1,680,026——-45.9%
▸ 10 SHAZSharonAI$52.4M2.42%958,864——-63.1%

Pro Feature

The remaining 108 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Clearline Capital LP hold as of Q3 2026?

Clearline Capital LP reported 118 positions worth $1.70B in its Q3 2026 13F filing. Largest positions: SPY (19.8%), CORZ (5.5%), AVGO (3.5%), AMZN (2.8%) and FTAI (2.7%).

What did Clearline Capital LP buy in Q3 2026?

New positions: SPY, WULF, IBIT, RRX and DKS (29 in all). Added to: CORZ, SHAZ, AVGO, AKAM and FTAI (33 in all).

What did Clearline Capital LP sell in Q3 2026?

Reduced: AMZN, AMD, MAX, NOVT and JHX (23 in all). Sold out entirely: IWM, ESTC, BILL, NCNO and AVTR (13 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.